SCHEMBL6946366

SCHEMBL6946366

NC(=O)c1cccc(O)c1N1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.58
MAPT P10636 5/20 0.48
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 4/20 0.48
HSD17B10 Q99714 4/20 0.48
HPGD P15428 3/20 0.48
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.46
POLB P06746 3/20 0.45
GAA P10253 2/20 0.45
MEN1 O00255 2/20 0.44
ALOX15 P16050 2/20 0.44
KMT2A Q03164 2/20 0.44
THRB P10828 1/20 0.44
GFER P55789 1/20 0.44
YWHAG P61981 1/20 0.44
PARP1 P09874 6/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP2 Q9UGN5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3681824 0.90 NPC1 (0.66) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL3682185 0.88 NPC1 (0.62) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL2505916 0.83 NPC1 (0.58) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL5092046 0.82 NPC1 (0.57) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL5092225 0.82 NPC1 (0.57) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL23708623 0.80 NPC1 (0.54) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL11432021 0.80 ALDH1A1 (0.44) MAPTALDH1A1KDM4EHSD17B10HPGD
SCHEMBL28046983 0.80 NPC1 (0.54) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL4041571 0.79 NPC1 (0.53) NPC1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL28228157 0.78 NPC1 (0.53) NPC1MAPTALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996446-B1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-09-17 EP disclosed
US-6562832-B1 Cytokine suppressive anti-inflammatory drugs, capable of inhibiting the CSBP/p38/RK kinase SMITHKLINE BEECHAM CORPORATION 2003-05-13 US disclosed
US-6046208-A TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ENDOTOXEMIA AND/OR TOXIC SHOCK SYNDROME, OTHER ACUTE OR CHRONIC INFLAMMATORY DISEASE STATES SUCH AS THE INFLAMMATORY REACTION INDUCED BY ENDOTOXIN OR INFLAMMATORY BOWEL DISEASE SMITHKLINE BEECHAM CORPORATION (US) 2000-04-04 US disclosed